Mass General | GenomeWeb

Mass General

Researchers incorporated deep phenotyping and gene expression profiles to tease apart gene networks that are altered in women with polycystic ovarian syndrome.

 The partners will use Namocell's Single Cell Dispenser platform for cell sorting and to capture CTCs.

An international team of researchers examined genetic and lifestyle factors linked to heart disease in some 55,600 people.

By analyzing the transcriptomes of more than 4,000 individual cells, researchers identified stem cell-like cellular subpopulations in six oligodendroglioma tumors.

The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis. 

The healthcare provider organizations are tasked with managing patient enrollment in the Precision Medicine Initiative.

Reversal for Some

Nature News writes that efforts like ExAC are enabling researchers to call some seemingly disease-linked variants as benign.

The Broad Institute-led team has published its procedures, preliminary findings, and possible future applications for the consortium's open access database.

By comparing pre-treatment and post-relapse samples from vemurafenib-treated melanoma patients, researchers uncovered resistance-related cohesin complex mutations.

The Massachusetts-based clinical gene editing firm has obtained exclusive rights to use the engineered Cas9 variants developed by one of its co-founders.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.